SOTK
$4.28
$0.06
Sono-Tek Corporation designs and manufactures ultrasonic coating systems for applying on parts and components for the microelectronics/electronics, alternative energy, medical, industrial, and research and development/other markets worldwide. It also designs and manufactures custom-engineered ultrasonic coating systems; and provides nozzles and generators for manufacturers' equipment. The company's products include integrated multi-axis coating systems, integrated coating systems, fluxing systems, OEM systems, and other related systems. It markets and distributes its products through independent distributors and sales representatives. The company was incorporated in 1975 and is based in Milton, New York.
Next Earnings
2026-01-11
Beta
-0.304
Average Volume
29650
Market Cap
67378217
Last Dividend
0
CIK
0000806172
ISIN
US8354831088
CUSIP
835483108
CEO
R. Stephen Harshbarger
Sector
Technology
Industry
Hardware, Equipment & Parts
Full Time Employees
82
IPO Date
1999-04-26
Status
Active
Latest News
| Title | Headline | Publisher | Date |
|---|---|---|---|
| Sono-Tek (SOTK) Projected to Post Earnings on Monday | Sono-Tek (NASDAQ: SOTK - Get Free Report) is expected to be announcing its Q3 2026 results before the market opens on Monday, January 12th. Analysts expect the company to announce earnings of $0.03 per share and revenue of $5.2490 million for the quarter. Interested persons can check the company's upcoming Q3 2026 earning summary page for | Defense World | 2026-01-05 01:07:18 |
| Financial Comparison: Broadcom (NASDAQ:AVGO) & Sono-Tek (NASDAQ:SOTK) | Broadcom (NASDAQ: AVGO - Get Free Report) and Sono-Tek (NASDAQ: SOTK - Get Free Report) are both computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership. Analyst Ratings This is a summary of recent | Defense World | 2025-12-30 02:08:48 |
| Sono-Tek (NASDAQ:SOTK) vs. Infineon Technologies (OTCMKTS:IFNNY) Head-To-Head Review | Infineon Technologies (OTCMKTS:IFNNY - Get Free Report) and Sono-Tek (NASDAQ: SOTK - Get Free Report) are both computer and technology companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation. Valuation and Earnings This table compares Infineon | Defense World | 2025-12-01 04:12:58 |
| Best Momentum Stocks to Buy for Oct. 21 | VSTM, AS and SOTK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Oct. 21, 2025. | Zacks Investment Research | 2025-10-21 11:01:52 |
| SonoTek (SOTK) Upgraded to Strong Buy: Here's What You Should Know | SonoTek (SOTK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. | Zacks Investment Research | 2025-10-15 13:01:27 |
| Sono-Tek Corporation (SOTK) Q2 2026 Earnings Call Transcript | Sono-Tek Corporation (NASDAQ:SOTK ) Q2 2026 Earnings Call October 14, 2025 10:30 AM EDT Company Participants Christopher Coccio - Executive Chairman R. Harshbarger - President, CEO & Director Stephen Bagley - Chief Financial Officer Conference Call Participants Kirin Smith - ProActive Capital Group, LLC Edward Jackson - Northland Capital Markets, Research Division Bill Nicklin Richard Ryan - Oak Ridge Financial Services Group Inc., Research Division Presentation Operator Good day, and welcome to the Sono-Tek Second Quarter and First Half Fiscal Year 2026 Results Conference Call. | Seeking Alpha | 2025-10-14 12:56:39 |
| Sono-Tek Corporation (SOTK) Q2 Earnings Beat Estimates | Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.02 per share a year ago. | Zacks Investment Research | 2025-10-14 09:26:04 |
| Sono-Tek Reports Fiscal Second Quarter Financial Results and Record First Half 2026 Revenue | - Reports Sixth Consecutive Quarter of Revenue over $5 million Highlighted by 150% Annual Increase in Medical Market Sales- -Fiscal First Half Net Income Increases 35%- -Backlog Increased 50% Sequentially Reflecting New Order Momentum- -Updates FY26 Guidance Reflecting Improved Outlook, Anticipating Modest Revenue Growth with Increasing Demand in the Medical Device Market- -Conference Call Today at 10:30 am ET- MILTON, N.Y., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for the second quarter and first half of fiscal year 2026, ended August 31, 2025. | GlobeNewsWire | 2025-10-14 07:10:00 |
| Sono-Tek Reports Fiscal Second Quarter Financial Results and Record First Half 2026 Revenue | – Reports Sixth Consecutive Quarter of Revenue over $5 million Highlighted by 150% Annual Increase in Medical Market Sales- -Fiscal First Half Net Income Increases 35%- -Backlog Increased 50% Sequentially Reflecting New Order Momentum- -Updates FY26 Guidance Reflecting Improved Outlook, Anticipating Modest Revenue Growth with Increasing Demand in the Medical Device Market- -Conference Call Today | MCAP MediaWire | 2025-10-14 07:00:07 |
| Sono-Tek Wins $2.8 Million Order for Advanced Medical Device Coating Systems | MILTON, N.Y., October 13, 2025 – – PRISM MediaWire (Press Release Service – Press Release Distribution) – Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has received a purchase order valued at over $2.8 million from a major U.S.-based medical device manufacturer. | MCAP MediaWire | 2025-10-13 07:04:48 |
| Sono-Tek Wins $2.8 Million Order for Advanced Medical Device Coating Systems | MILTON, N.Y., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it has received a purchase order valued at over $2.8 million from a major U.S.based medical device manufacturer. | GlobeNewsWire | 2025-10-13 07:00:00 |
SEC Filings
| Type | Filing Date | Accepted Date | Link |
|---|---|---|---|
| 8-K | 2025-11-12 | 2025-11-12 | View Filing |
| 8-K | 2025-11-12 | 2025-11-12 | View Filing |
| 4 | 2025-10-24 | 2025-10-24 | View Filing |
| 4 | 2025-10-23 | 2025-10-23 | View Filing |
| 10-Q | 2025-10-14 | 2025-10-14 | View Filing |
| 8-K | 2025-10-14 | 2025-10-14 | View Filing |
| 8-K | 2025-10-14 | 2025-10-14 | View Filing |
| 8-K | 2025-09-03 | 2025-09-03 | View Filing |
| 8-K | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 4 | 2025-08-25 | 2025-08-25 | View Filing |
| 8-K | 2025-08-21 | 2025-08-21 | View Filing |
| 4 | 2025-08-20 | 2025-08-20 | View Filing |
| 4 | 2025-08-11 | 2025-08-11 | View Filing |
| ARS | 2025-07-25 | 2025-07-25 | View Filing |
| DEF 14A | 2025-07-25 | 2025-07-25 | View Filing |
| 4 | 2025-07-24 | 2025-07-24 | View Filing |
| 4 | 2025-07-23 | 2025-07-23 | View Filing |
| 4/A | 2025-07-23 | 2025-07-23 | View Filing |
| 4 | 2025-07-18 | 2025-07-18 | View Filing |
| 10-Q | 2025-07-10 | 2025-07-10 | View Filing |
| 8-K | 2025-07-10 | 2025-07-10 | View Filing |
| 3 | 2025-06-17 | 2025-06-17 | View Filing |
| SD | 2025-05-30 | 2025-05-30 | View Filing |
| 8-K | 2025-05-28 | 2025-05-28 | View Filing |
| 10-K | 2025-05-28 | 2025-05-28 | View Filing |
| 8-K | 2025-05-28 | 2025-05-28 | View Filing |
| 8-K | 2025-04-23 | 2025-04-23 | View Filing |
| 8-K | 2025-04-09 | 2025-04-09 | View Filing |
| 4 | 2025-03-26 | 2025-03-26 | View Filing |
| 8-K | 2025-02-19 | 2025-02-19 | View Filing |
| 4 | 2025-01-28 | 2025-01-28 | View Filing |
| 10-Q | 2025-01-13 | 2025-01-13 | View Filing |
| 8-K | 2025-01-13 | 2025-01-13 | View Filing |
| SC 13G/A | 2025-01-06 | 2025-01-06 | View Filing |
| SC 13G | 2024-12-16 | 2024-12-16 | View Filing |
| 4 | 2024-11-08 | 2024-11-08 | View Filing |
| 8-K | 2024-11-04 | 2024-11-04 | View Filing |
| S-8 | 2024-10-15 | 2024-10-16 | View Filing |
| 10-Q | 2024-10-15 | 2024-10-15 | View Filing |
| 8-K | 2024-10-15 | 2024-10-15 | View Filing |
| 4 | 2024-08-27 | 2024-08-27 | View Filing |
| 8-K | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-23 | 2024-08-23 | View Filing |
| 4 | 2024-08-22 | 2024-08-22 | View Filing |
| 4 | 2024-08-12 | 2024-08-12 | View Filing |
| 4 | 2024-08-08 | 2024-08-08 | View Filing |
| 4 | 2024-07-29 | 2024-07-29 | View Filing |
| DEF 14A | 2024-07-25 | 2024-07-25 | View Filing |
| ARS | 2024-07-25 | 2024-07-25 | View Filing |
| 4 | 2024-07-24 | 2024-07-24 | View Filing |
| 10-Q | 2024-07-11 | 2024-07-11 | View Filing |
| 8-K | 2024-07-11 | 2024-07-11 | View Filing |
| 8-K | 2024-07-01 | 2024-07-01 | View Filing |
| SD | 2024-05-30 | 2024-05-30 | View Filing |
| 10-K | 2024-05-23 | 2024-05-23 | View Filing |
| 8-K | 2024-05-23 | 2024-05-23 | View Filing |
| 8-K | 2024-04-08 | 2024-04-08 | View Filing |
| 3 | 2024-04-05 | 2024-04-05 | View Filing |
| 8-K | 2024-04-03 | 2024-04-03 | View Filing |
| 4 | 2024-02-27 | 2024-02-27 | View Filing |
| 4 | 2024-02-27 | 2024-02-27 | View Filing |
| 4 | 2024-02-22 | 2024-02-22 | View Filing |
| 4 | 2024-02-08 | 2024-02-08 | View Filing |
| 4 | 2024-02-06 | 2024-02-06 | View Filing |
| 4 | 2024-02-01 | 2024-02-01 | View Filing |
| SC 13G/A | 2024-01-31 | 2024-01-31 | View Filing |
| 4 | 2024-01-30 | 2024-01-30 | View Filing |
| 4 | 2024-01-26 | 2024-01-26 | View Filing |
| 4 | 2024-01-24 | 2024-01-24 | View Filing |
| 4 | 2024-01-24 | 2024-01-24 | View Filing |
| 4 | 2024-01-23 | 2024-01-23 | View Filing |
| 10-Q | 2024-01-16 | 2024-01-16 | View Filing |
| 8-K | 2024-01-16 | 2024-01-16 | View Filing |
Algorithm Performance
| Algorithm | Profit/Loss | Profit Factor | # Trades | Sharpe | Sortino | Efficiency |
|---|---|---|---|---|---|---|
| Larry Williams PercentR Strategy | 18.10% | 1 | 113 | 0.04 | 0.08 | 23.17 |
| Neural Forcast | 17.54% | 1 | 438 | 0.03 | 0.04 | 22.62 |
| Keltner Channel Strategy | 17.38% | 0.99 | 89 | 0.04 | 0.06 | 22.45 |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xxx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xxx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | x | xxx | xxxx | xxxx | xxxxx |
| xxxxxxxxx | xxxxxxx% | x | xxx | xxxx | xxxx | xxxxx |
| xxxxxxxxxxxx | xxxxxxx% | x | xxx | x | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxxx | xxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | x | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxx% | xxxx | x | x | xxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | x% | x | xxx | x | x | xxxx |
| xxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xx | xxxxx | x | xxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxx | xxxxxxx% | x | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | x |
| xxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxx | xxxxxxxx% | xxxx | x | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxx | xxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxx |
| xxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxx |
| xxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxx | xxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | x | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxx | xxxx | xxxxx |
| xxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxxx |
| xxxxxxxxxxxxxxxxxxxx | xxxxxxxx% | xxxx | xxx | xxxxx | xxxxx | xxxx |